115 Search Results
During the coronavirus pandemic, one vitally important topic not receiving much public and media attention is how to keep the “at-risk” patient population on therapy. Intouch B2D has a plan.
While pharmaceutical companies have long been the target of public mistrust and negative media attention, right now the industry is doing more than its fair share of rolling up its sleeves to help.
The COVID-19 pandemic is a powerful trigger that will change human behaviors and accelerate adoption of new methods of scientific information-sharing among medical professionals, powered by technology and virtual forms of collaboration. This POV looks at the challenges and opportunities when navigating this new world.
Intouch is committed to sharing information about how the pharma marketing industry is adapting to challenges presented by COVID-19, as well as how Intouch Group and its affiliates can help clients work within the evolving parameters we face. In that spirit, our sister affiliate, Intouch B2D, recently asked clients large and small, “What are you […]
As the situation with the coronavirus (COVID-19) continues to evolve, Intouch is proactively monitoring its impact on our clients’ businesses. With that in mind, Intouch Media’s social team has been working hard to create a Twitter presence completely dedicated to COVID-19, @IntouchCovid19.
Due to COVID-19 and its impact on people and health systems, pharmaceutical marketers will be seeking new ways to engage with their customers. This POV will address those challenges and also elaborate on the opportunities pharma marketers have to help their healthcare customers, as well as patients, and build relationships with both audiences for the future, once this health crisis has passed.
Download the POV, The Digital Determinants of Health, to discover how understanding digital determinants of health can transform pharmaceutical strategies and drive business success.
In a recent article for PM360, Susan Perlbachs, Chief Creative Officer at EVERSANA INTOUCH, delves into the growing trend of celebrity influencers in pharmaceutical advertising, exploring both the opportunities and challenges they present. She highlights how celebrities can provide brands with instant recognition and broad reach, sharing examples like Travis Kelce’s involvement in Pfizer’s “Got […]
Every year, ESMO brings together experts from pharma, research and advocacy organizations, and HCPs to hear about the year’s biggest oncology breakthroughs. This year’s theme was “Shaping the Future of Anticancer Therapies.”
Discover how a hybrid event was tailored to extend stakeholder engagement and maximize impact to help pharma teams generate attention and drive engagement pre-, during, and post-event.
Page 3 of 12